ResearcherIndiana University School of MedicineNo recent work listed

Bryan K. Holcomb

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0001-1288-5243; OpenAlex author ID A5109926956. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2012: 1 paper

Papers 1

Dimethylamino parthenolide enhances the inhibitory effects of gemcitabine in human pancreatic cancer cells. Co-author DOI 10.1007/s11605-012-1913-7 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Michele Yip-Schneider · 1 shared paper, 2012 · strength 0.04
- Paper Dimethylamino parthenolide enhances the inhibitory effects of gemcitabine in human pancreatic cancer cells. DOI 10.1007/s11605-012-1913-7 ↗
Joal D. Beane · 1 shared paper, 2012 · strength 0.04
- Paper Dimethylamino parthenolide enhances the inhibitory effects of gemcitabine in human pancreatic cancer cells. DOI 10.1007/s11605-012-1913-7 ↗
Joshua A. Waters · 1 shared paper, 2012 · strength 0.04
- Paper Dimethylamino parthenolide enhances the inhibitory effects of gemcitabine in human pancreatic cancer cells. DOI 10.1007/s11605-012-1913-7 ↗
Christian Max Schmidt · 1 shared paper, 2012 · strength 0.04
- Paper Dimethylamino parthenolide enhances the inhibitory effects of gemcitabine in human pancreatic cancer cells. DOI 10.1007/s11605-012-1913-7 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.